Get quick answers to your questions about the article from our AI researcher chatbot
{'id': 'https://openalex.org/W4282971798', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-3595', 'title': 'Abstract 3595: RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers', 'display_name': 'Abstract 3595: RMC-6291, a next-generation tri-complex KRASG12C(ON) inhibitor, outperforms KRASG12C(OFF) inhibitors in preclinical models of KRASG12C cancers', 'publication_year': 2022, 'publication_date': '2022-06-15', 'ids': {'openalex': 'https://openalex.org/W4282971798', 'doi': 'https://doi.org/10.1158/1538-7445.am2022-3595'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-3595', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5103986436', 'display_name': 'Robert J. Nichols', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Robert J. Nichols', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5020727899', 'display_name': 'Yu Chi Yang', 'orcid': 'https://orcid.org/0000-0001-8318-1174'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Y.C. Yang', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5078573857', 'display_name': 'Jim Cregg', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jim Cregg', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5085646397', 'display_name': 'Chris J. Schulze', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Chris J. Schulze', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5055357640', 'display_name': 'Zhican Wang', 'orcid': 'https://orcid.org/0000-0002-9411-9349'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Zhican Wang', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039253772', 'display_name': 'Richa Dua', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Richa Dua', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5101768843', 'display_name': 'Jingjing Jiang', 'orcid': 'https://orcid.org/0000-0002-5646-6040'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jingjing Jiang', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5058881772', 'display_name': 'Lindsay S. Garrenton', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Lindsay S. Garrenton', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5011524529', 'display_name': 'Nicole Nasholm', 'orcid': 'https://orcid.org/0000-0002-5451-4985'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Nicole Nasholm', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5071778044', 'display_name': 'Alun Bermingham', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Alun Bermingham', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5041603099', 'display_name': 'John E. Knox', 'orcid': 'https://orcid.org/0009-0006-6246-5198'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'John E. Knox', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5039694843', 'display_name': 'Kyle J. Seamon', 'orcid': 'https://orcid.org/0009-0005-5028-3752'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kyle Seamon', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5007112365', 'display_name': 'Michael Longhi', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Michael Longhi', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5002869939', 'display_name': 'Kang-Jye Chou', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Kang-Jye Chou', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5026492211', 'display_name': 'Shaoling Li', 'orcid': 'https://orcid.org/0000-0002-7621-3091'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Shaoling Li', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5038156337', 'display_name': 'David Wildes', 'orcid': 'https://orcid.org/0009-0009-3855-7270'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'David P. Wildes', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5057362852', 'display_name': 'Mallika Singh', 'orcid': 'https://orcid.org/0009-0003-0234-1589'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Mallika Singh', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5040036103', 'display_name': 'Elena S. Koltun', 'orcid': 'https://orcid.org/0009-0005-8720-9097'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Elena S. Koltun', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5022776516', 'display_name': 'Adrian L. Gill', 'orcid': 'https://orcid.org/0009-0003-0914-4860'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Adrian L. Gill', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5027330002', 'display_name': 'Jacqueline A.M. Smith', 'orcid': 'https://orcid.org/0000-0001-5028-8725'}, 'institutions': [{'id': 'https://openalex.org/I4210100604', 'display_name': 'Revolution Medicines (United States)', 'ror': 'https://ror.org/00mny1y94', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I4210100604']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Jacqueline A.M. Smith', 'raw_affiliation_strings': ['1Revolution Medicines, Redwood City, CA.'], 'affiliations': [{'raw_affiliation_string': '1Revolution Medicines, Redwood City, CA.', 'institution_ids': ['https://openalex.org/I4210100604']}]}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 3.084, 'has_fulltext': False, 'cited_by_count': 24, 'citation_normalized_percentile': {'value': 0.999981, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 96, 'max': 97}, 'biblio': {'volume': '82', 'issue': '12_Supplement', 'first_page': '3595', 'last_page': '3595'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9945, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, 'topics': [{'id': 'https://openalex.org/T12620', 'display_name': 'Signaling Pathways in Disease', 'score': 0.9945, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T11041', 'display_name': 'Ubiquitin and proteasome pathways', 'score': 0.9921, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}, {'id': 'https://openalex.org/T13526', 'display_name': '14-3-3 protein interactions', 'score': 0.9898, 'subfield': {'id': 'https://openalex.org/subfields/1312', 'display_name': 'Molecular Biology'}, 'field': {'id': 'https://openalex.org/fields/13', 'display_name': 'Biochemistry, Genetics and Molecular Biology'}, 'domain': {'id': 'https://openalex.org/domains/1', 'display_name': 'Life Sciences'}}], 'keywords': [], 'concepts': [{'id': 'https://openalex.org/C502942594', 'wikidata': 'https://www.wikidata.org/wiki/Q3421914', 'display_name': 'Cancer research', 'level': 1, 'score': 0.54310066}, {'id': 'https://openalex.org/C2781187634', 'wikidata': 'https://www.wikidata.org/wiki/Q20969980', 'display_name': 'KRAS', 'level': 4, 'score': 0.4108507}, {'id': 'https://openalex.org/C121608353', 'wikidata': 'https://www.wikidata.org/wiki/Q12078', 'display_name': 'Cancer', 'level': 2, 'score': 0.35019284}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.30692148}, {'id': 'https://openalex.org/C526805850', 'wikidata': 'https://www.wikidata.org/wiki/Q188874', 'display_name': 'Colorectal cancer', 'level': 3, 'score': 0.22968993}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.20145246}], 'mesh': [], 'locations_count': 1, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.1158/1538-7445.am2022-3595', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S168522863', 'display_name': 'Cancer Research', 'issn_l': '0008-5472', 'issn': ['0008-5472', '1538-7445'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4310320273', 'host_organization_name': 'American Association for Cancer Research', 'host_organization_lineage': ['https://openalex.org/P4310320273'], 'host_organization_lineage_names': ['American Association for Cancer Research'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'score': 0.42, 'id': 'https://metadata.un.org/sdg/8', 'display_name': 'Decent work and economic growth'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W4389568370', 'https://openalex.org/W4367603427', 'https://openalex.org/W3093086801', 'https://openalex.org/W3032375762', 'https://openalex.org/W3031052312', 'https://openalex.org/W2748952813', 'https://openalex.org/W2586801360', 'https://openalex.org/W2080531066', 'https://openalex.org/W1995515455', 'https://openalex.org/W1686926070'], 'abstract_inverted_index': {'Abstract': [0], 'The': [1, 42, 185], 'KRASG12C': [2, 119, 229, 257, 312, 424], 'mutation': [3], 'is': [4, 161, 333], 'found': [5], 'in': [6, 22, 48, 131, 228, 237, 293, 347, 420], '11%': [7], 'of': [8, 14, 19, 34, 46, 65, 84, 93, 103, 111, 118, 126, 156, 166, 195, 206, 212, 217, 224, 248, 256, 269, 273, 279, 305, 338, 343, 356, 423, 429], 'non-small': [9], 'cell': [10, 252], 'lung': [11], 'cancers,': [12, 16], '4%': [13], 'colorectal': [15], 'and': [17, 25, 55, 145, 177, 210, 221, 232, 251, 276, 285, 296], '2%': [18], 'pancreatic': [20], 'cancers': [21, 28, 76, 425], 'the': [23, 31, 37, 57, 70, 85, 101, 121, 147, 267, 271, 277, 353, 430], 'U.S.,': [24], 'drives': [26, 233], 'these': [27], 'by': [29, 265, 302, 350], 'shifting': [30], 'cellular': [32], 'equilibrium': [33], 'KRAS': [35], 'towards': [36], 'GTP-bound,': [38], 'active': [39, 354], 'state,': [40, 88], 'KRASG12C(ON).': [41, 97], 'resulting': [43], 'increased': [44, 298], 'levels': [45], 'KRASG12C(ON)': [47, 127, 167, 176, 189, 213, 339, 415], 'turn': [49], 'increase': [50], 'signaling': [51, 191], 'output': [52], 'to': [53, 105, 120, 313, 329], 'initiate': [54], 'support': [56], 'oncogenic': [58, 95, 359], 'state.': [59], 'In': [60, 199, 242], 'recent': [61], 'years,': [62], 'a': [63, 129, 141, 153, 162, 170, 181, 243, 262, 334, 412], 'class': [64, 110], 'KRASG12C(OFF)': [66, 106, 263, 345, 418], 'inhibitors': [67, 80, 107, 289, 346, 419], 'has': [68], 'transformed': [69], 'treatment': [71, 282], 'landscape': [72], 'for': [73, 433], 'patients': [74], 'with': [75, 128, 283, 311, 321], 'bearing': [77], 'KRASG12C.': [78, 159], 'These': [79], 'work': [81], 'via': [82, 192], 'sequestration': [83], 'GDP-bound,': [86], 'inactive': [87], 'KRASG12C(OFF),': [89], 'starving': [90], 'cancer': [91, 315, 327], 'cells': [92, 174], 'their': [94], 'driver,': [96], 'Recent': [98], 'reports': [99], 'on': [100], 'nature': [102], 'resistance': [104], 'suggest': [108], 'this': [109, 357], 'drugs': [112], 'can': [113], 'be': [114, 152], 'overcome': [115], 'through': [116], 'reactivation': [117, 304], 'ON': [122], 'form.': [123], 'Direct': [124], 'inhibition': [125], 'first': [130], 'class,': [132], 'potent,': [133], 'orally': [134], 'bioavailable,': [135], 'selective,': [136], 'tri-complex': [137, 171, 187, 414], 'inhibitor': [138, 155, 165, 337], 'RMC-6291,': [139, 411], 'represents': [140], 'more': [142], 'robust': [143], 'approach': [144], 'presents': [146], 'possibility': [148], 'that': [149, 168, 309, 340], 'RMC-6291': [150, 160, 218, 259, 284, 317, 332], 'will': [151], '‘best-in-class’': [154], 'tumors': [157], 'harboring': [158], 'potent': [163], 'covalent': [164], 'forms': [169], 'within': [172], 'tumor': [173, 230, 235, 274], 'between': [175], 'cyclophilin': [178], 'A': [179], '(CypA),': [180], 'highly': [182], 'abundant': [183], 'immunophilin.': [184], 'assembled': [186], 'prevents': [188], 'from': [190], 'steric': [193], 'blockade': [194], 'RAS': [196, 207, 225, 307], 'effector': [197, 208], 'binding.': [198], 'cells,': [200], 'kinetic': [201], 'analyses': [202], 'demonstrate': [203], 'near-immediate': [204], 'disruption': [205], 'binding': [209], 'extinction': [211], 'signaling.': [214], 'Oral': [215], 'administration': [216], 'produces': [219], 'deep': [220], 'durable': [222], 'suppression': [223], 'pathway': [226], 'activity': [227], 'models': [231, 255, 295, 328, 349, 422], 'profound': [234], 'regressions': [236], 'vivo': [238], 'at': [239], 'well-tolerated': [240], 'doses.': [241], 'mouse': [244], 'clinical': [245], 'trial': [246], 'consisting': [247], 'multiple': [249], 'patient-': [250], 'line-derived': [253], 'xenograft': [254], 'NSCLC,': [258], 'outperformed': [260], 'adagrasib,': [261], 'inhibitor,': [264, 416], 'increasing': [266], 'number': [268], 'responses,': [270], 'depth': [272], 'regressions,': [275], 'durability': [278], 'responses.': [280], 'Combination': [281], 'SHP2': [286], 'or': [287], 'SOS1': [288], 'was': [290], 'well': [291, 320], 'tolerated': [292], 'preclinical': [294, 348, 421], 'further': [297], 'anti-tumor': [299, 330], 'activity,': [300], 'likely': [301], 'preventing': [303], 'wild-type': [306], 'proteins': [308], 'cooperate': [310], 'fuel': [314], 'growth.': [316], 'also': [318], 'combined': [319], 'immune': [322], 'checkpoint': [323], 'inhibitors,': [324], 'sensitizing': [325], 'KRASG12C-bearing': [326], 'immunity.': [331], 'next-generation,': [335], 'mutant-selective': [336], 'overcomes': [341], 'limitations': [342], 'first-generation': [344], 'directly': [351], 'targeting': [352], 'form': [355], 'important': [358], 'driver.': [360], 'Citation': [361], 'Format:': [362], 'Robert': [363], 'J.': [364, 371], 'Nichols,': [365], 'Y.C.': [366], 'Yang,': [367], 'Jim': [368], 'Cregg,': [369], 'Chris': [370], 'Schulze,': [372], 'Zhican': [373], 'Wang,': [374], 'Richa': [375], 'Dua,': [376], 'Jingjing': [377], 'Jiang,': [378], 'Lindsay': [379], 'S.': [380, 403], 'Garrenton,': [381], 'Nicole': [382], 'Nasholm,': [383], 'Alun': [384], 'Bermingham,': [385], 'John': [386], 'E.': [387], 'Knox,': [388], 'Kyle': [389], 'Seamon,': [390], 'Michael': [391], 'Longhi,': [392], 'Kang-Jye': [393], 'Chou,': [394], 'Shaoling': [395], 'Li,': [396], 'David': [397], 'P.': [398], 'Wildes,': [399], 'Mallika': [400], 'Singh,': [401], 'Elena': [402], 'Koltun,': [404], 'Adrian': [405], 'L.': [406], 'Gill,': [407], 'Jacqueline': [408], 'A.M.': [409], 'Smith.': [410], 'next-generation': [413], 'outperforms': [417], '[abstract].': [426], 'In:': [427], 'Proceedings': [428], 'American': [431], 'Association': [432], 'Cancer': [434, 445], 'Research': [435], 'Annual': [436], 'Meeting': [437], '2022;': [438], '2022': [439], 'Apr': [440], '8-13.': [441], 'Philadelphia': [442], '(PA):': [443], 'AACR;': [444], 'Res': [446], '2022;82(12_Suppl):Abstract': [447], 'nr': [448], '3595.': [449]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W4282971798', 'counts_by_year': [{'year': 2024, 'cited_by_count': 8}, {'year': 2023, 'cited_by_count': 13}, {'year': 2022, 'cited_by_count': 2}], 'updated_date': '2024-12-25T02:37:14.905210', 'created_date': '2022-06-17'}